#Geftinat is an #anti-cancer medication containing the drug #Gefitinib as active substance in it, which is an inhibitor that interrupts signaling through the epidermal growth factor receptor (EGFR) in target cells, thus helping in slowing down the growth of #cancer cells. #Gefitinib250mg is mainly used in treatment of non-small cell #lungcancer. You can get Geftinat manufactured by Natco at economical prices from us, Call: +91-9873336444, QQ: 152
Human 'Atlas' Reveals Where Proteins Reside in the Body
An image of a protein called EGFR (epidermal growth factor receptor) in human cells viewed under a microscope. EGFR, which is shown in green, is localized to the cell's membrane. The cell's nucleus is shown in blue.
Ribociclib plus letrozole is associated with significantly longer progression-free survival for patients receiving initial systemic treatment for hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer, according to a study published online Oct. 8 in the New England Journal of Medicine. The research was published to coincide with the annual European Society of Medical Oncology Congress, held from Oct. 7 to 11 in Copenhagen, Denmark.
#LungCancer #NonSmallCellLungCancer #CancerResearch With the new cobas Epidermal Growth Factor Receptor test, doctors at some public hospitals are now able to detect the presence of gene mutations. About half of non-small cell lung cancer is linked to a genetic epidermal growth factor receptor (EGFR) mutation - affecting mostly female non-smokers.
Epidermal Growth Factor Receptor and Its Applications - The discovery of growth factors won the Nobel Prize in Medicine in 1986, implying their importance. Epidermal growth factor receptor, EGFR, one of such factors, exists on cell surface and is activated by binding of its specific ligands. EGFR is a member of the receptor tyrosine kinase family whose members play a critical role in oncogenesis. Mutations affecting EGFR expression or activity could result in cancers, ...